LERA SAUPPE: Open Payments
NPI 1083899462 · MONTROSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$730 in 5 payments from 5 companies in 2025. Trend: 2023 $379 · 2024 $238 · 2025 $730
Food & beverage: $730
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $197 |
| Madrigal Pharmaceuticals | 1 | $145 |
| Alnylam Pharmaceuticals Inc. | 1 | $144 |
| Abbott Laboratories | 1 | $122 |
| Novo Nordisk Inc | 1 | $122 |
Products named: SAPIEN 3 Ultra RESILIA, REZDIFFRA, ONPATTRO, ALINITY, Ozempic.
Industry payments across CA — which companies pay providers there.
